Navigation Links
uBiome Receives Patent for Diagnostics and Therapeutics for Endocrine System Conditions
Date:12/28/2018

uBiome, the leader in microbial genomics, announced the issue of patent number 9,760,676 entitled “Method and System for Microbiome-Derived Diagnostics and Therapeutics for Endocrine System Conditions” by the US Patent and Trademark Office on September 12, 2017 with a priority date of October 21, 2014. The patent is an invention by uBiome collaborators Dr. Zachary Apte, Dr. Daniel Almonacid, Dr. Jessica Richman, and Dr. Siavosh Rezvan Behbahani, and expands upon its current intellectual property portfolio.

The patented technology involves diagnosing an endocrine system condition such as chronic fatigue syndrome, Graves’ disease, Hashimoto’s thyroiditis, metabolic disease, obesity, and Type I and II diabetes, and generating a therapy model using biological samples from uBiome’s proprietary database.

This issuance will lead to further development in predicting the likelihood of occurrence of endocrine system conditions in individuals and in designing therapies for these endocrine system conditions, which may include the modification of the microbiota using prebiotics and probiotics. Together, these potential impacts could improve the treatment and management of endocrine system conditions in individuals.

“This patent allows uBiome to continue its mission of advancing the science of the microbiome and making it useful to people, especially those affected by chronic endocrine conditions, which in some cases are difficult to diagnose and manage,” Jessica Richman, PhD, co-founder and CEO of uBiome, said. “The expansion of our patent portfolio and intellectual property demonstrates our dedication to achieving this mission.”

For more information about our science and patents, visit http://www.ubiome.com/science/#patents.

_____
About uBiome
Founded in 2012, uBiome is the leader in microbial genomics. The Company’s mission is to advance the science of the microbiome and make it useful to people. uBiome combines its patented proprietary precision sequencing™ with machine learning and artificial intelligence to develop wellness products, clinical tests, and therapeutic targets. uBiome has filed for over 250 patents on its technology, which includes sample preparation, computational analysis, molecular techniques, as well as diagnostic and therapeutic applications.

uBiome’s commercial products include SmartGut™, the world’s first sequencing-based clinical microbiome test, which identifies microbes in the gut for patients with chronic gut conditions such as IBD, IBS, Crohn’s Disease, and ulcerative colitis; SmartJane™, the first sequencing-based women’s health screening test, which genotypes all 19 clinically relevant strains of HPV, identifies four common STDs, and surveys more than 20 vaginal microbes associated with bacterial vaginosis and other conditions; and Explorer™, a health and wellness product to understand the role that food and lifestyle can play in wellness.

uBiome’s platform has been used by hundreds of thousands of consumers, patients, and doctors and more than 200 research institutions around the world, including the US Centers for Disease Control (CDC), US National Institutes of Health (NIH), Harvard University, Stanford University, the Massachusetts Institute of Technology (MIT), University of California, San Francisco, Oxford University, and the University of Sydney.

Since its launch, the company has received widespread recognition including CNN 10: Startups to Watch, the IVY Technology Award, CNN Future 30, and was named one of Fast Company’s Most Innovative Companies in Healthcare in 2016 and in Data Science in 2018, as well as a Technology Pioneer from the World Economic Forum in 2018. For more information, visit http://www.uBiome.com.

Read the full story at https://www.prweb.com/releases/ubiome_receives_patent_for_diagnostics_and_therapeutics_for_endocrine_system_conditions/prweb15995198.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related medicine news :

1. uBiome Receives Patent for Diagnostics and Therapeutics for Microbiome Functional Features
2. uBiome Awards Grant to Florida State University to Study Effect of Dietary Intervention on Bone Health in Men
3. uBiome Awards Grant to The Ohio State University to Study Microbiome Composition in Perinatal Women and Their Infants
4. uBiome Awards Grant to Team of Urology Researchers at UCLA to Investigate Dietary Intervention in Prostate Cancer
5. uBiome Awards Grant to University of Alicante Researchers to Study Influence of Diet on Gut Microbiome and Sports Performance
6. uBiome Appoints Dr. Katie Pollard, PhD, Director of the Gladstone Institute of Data Science and Biotechnology, to its Scientific Advisory Board
7. uBiome’s Dental Campaign to Give Portion of Proceeds to Charitable Dental Organization
8. uBiome Launches World's First Dental Citizen Science Campaign
9. uBiome Adds Dr. Spencer Wells to Advisory Board
10. Florida Hospital Receives National Honor for Patient Experience
11. Veran Medical Receives $20M Investment from BTG
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/11/2019)... ... 2019 , ... Dr. John V. Prunskis, co-founder and co-Medical Director of the ... Management Best Practices Task Force (Pain Task Force) met last Monday with Joe Grogan, ... the HHS Pain Task Force’s final report that was submitted to Congress in May ...
(Date:11/9/2019)... ... November 08, 2019 , ... The Women’s Dermatologic Society (WDS) announced that Marta ... WDS Board of Directors appointed Molly Hinshaw, MD to fill the remainder of Dr. ... 2020 term and will be presented to the membership as the 2020-2021 President at ...
(Date:11/9/2019)... ... ... Mount Sinai Medical-Legal Partnership (MSMLP), an organization formed to address the legal needs ... and advocacy assistance to families and patients in need. The announcement was made at ... of Blaine (“Fin”) Fogg, who was a member of the Boards of Trustees of ...
(Date:11/7/2019)... , ... November 06, 2019 , ... Atlantic Ultraviolet Corporation ... flu is to get the flu shot. Since the flu season starts in October ... in early Fall, where their employees can simply sign-up and get their shot. , ...
(Date:11/7/2019)... ... 2019 , ... ALZYN, LLC today announced that The Silicon Review Magazine has ... “The Silicon Review 50 Best Companies to Watch 2019 program identifies companies which are ... winning a spot on this list indicates the company has distinguished itself from peers ...
Breaking Medicine News(10 mins):
(Date:11/6/2019)... ... November 06, 2019 , ... Doral Health & Wellness, ... Adult Day Care Center on Pitkin Avenue in the Brownsville section of Brooklyn. ... managing and preventing diabetes. Seniors can take part in fitness and meditation classes, ...
(Date:11/6/2019)... ... November 06, 2019 , ... On ... Westchester Hospital (NWH) President and CEO, Joel Seligman, with the Make A Difference ... commitment to raising awareness, providing education and registering lifesaving donors. Assemblyman David Buchwald, ...
(Date:11/5/2019)... Va. (PRWEB) , ... November ... ... Interactive Workshops, Wednesday-Thursday, Nov. 13-14: How to Build a Sponsor Risk Management ... Resources International, Inc., Wednesday-Friday, Nov. 13-15, 2019 • Philadelphia, PA , ...
Breaking Medicine Technology: